Novo Nordisk cuts direct-to-consumer prices for Wegovy and Ozempic

Name: Novo Nordisk cuts direct-to-consumer prices for Wegovy and Ozempic
Uploaded: 2025-11-18T14:36:06Z
Duration: 23 s
Description: Pharmaceutical company Novo Nordisk is reducing the direct-to-consumer monthly cost of its popular weight loss and diabetes drugs, Wegovy and Ozempic, from $499 to $349. This significant price cut is a departure from their original $1000 per month price tag. Additionally, an introductory offer allows patients paying cash to get the first two months for $199.

Mornings With Maria · FBN · Nov 18, 2025 · 23sSign Up Now

Already a subscriber?

Pharmaceutical company Novo Nordisk is reducing the direct-to-consumer monthly cost of its popular weight loss and diabetes drugs, Wegovy and Ozempic, from $499 to $349. This significant price cut is a departure from their original $1000 per month price tag. Additionally, an introductory offer allows patients paying cash to get the first two months for $199.